Literature DB >> 17192354

Serum interleukin-18 levels are increased and closely associated with various soluble adhesion molecule levels in type 1 diabetic patients.

Naoto Katakami1, Hideaki Kaneto, Munehide Matsuhisa, Kazutomi Yoshiuchi, Ken Kato, Kaoru Yamamoto, Yutaka Umayahara, Keisuke Kosugi, Masatsugu Hori, Yoshimitsu Yamasaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17192354     DOI： 10.2337/dc06-1768

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  11 in total

1.  IL-18 is required for self-reactive T cell expansion in NOD mice.

Authors:  Annette M Marleau; Nora E Sarvetnick
Journal:  J Autoimmun       Date:  2011-03-16       Impact factor: 7.094

2.  Interleukin-18 plays a dispensable role in murine and likely also human bone marrow failure.

Authors:  Zhijie Wu; Valentina Giudice; Jichun Chen; Wanling Sun; Zenghua Lin; Keyvan Keyvanfar; Nidhi Talasani; Sachiko Kajigaya; Xingmin Feng; Neal S Young
Journal:  Exp Hematol       Date:  2018-10-12       Impact factor: 3.084

3.  Increased expression of IL-18 in the serum and islets of type 1 diabetics.

Authors:  Robert Z Harms; Danielle N Yarde; Zachary Guinn; Kristina M Lorenzo-Arteaga; Kevin P Corley; Monina S Cabrera; Nora E Sarvetnick
Journal:  Mol Immunol       Date:  2015-01-07       Impact factor: 4.407

Review 4.  IL-18 in inflammatory and autoimmune disease.

Authors:  Saikiran K Sedimbi; Thomas Hägglöf; Mikael C I Karlsson
Journal:  Cell Mol Life Sci       Date:  2013-07-27       Impact factor: 9.261

5.  Genetic association analyses of atopic illness and proinflammatory cytokine genes with type 1 diabetes.

Authors:  Nada M Saleh; Srilakshmi M Raj; Deborah J Smyth; Chris Wallace; Joanna M M Howson; Louise Bell; Neil M Walker; Helen E Stevens; John A Todd
Journal:  Diabetes Metab Res Rev       Date:  2011-11       Impact factor: 4.876

6.  Altered CD161 bright CD8+ mucosal associated invariant T (MAIT)-like cell dynamics and increased differentiation states among juvenile type 1 diabetics.

Authors:  Robert Z Harms; Kristina M Lorenzo; Kevin P Corley; Monina S Cabrera; Nora E Sarvetnick
Journal:  PLoS One       Date:  2015-01-27       Impact factor: 3.240

7.  Elevated levels of serum IL-12 and IL-18 are associated with lower frequencies of CD4(+)CD25 (high)FOXP3 (+) regulatory t cells in young patients with type 1 diabetes.

Authors:  Monika Ryba-Stanisławowska; Karolina Rybarczyk-Kapturska; Małgorzata Myśliwiec; Jolanta Myśliwska
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

8.  Per os colchicine administration in cholesterol fed rabbits: Triglycerides lowering effects without affecting atherosclerosis progress.

Authors:  Vaios Vasileios Kaminiotis; George Agrogiannis; Panagiotis Konstantopoulos; Vasiliki Androutsopoulou; Laskarina Maria Korou; Ioannis S Vlachos; Ismene A Dontas; Despina Perrea; Dimitrios C Iliopoulos
Journal:  Lipids Health Dis       Date:  2017-09-26       Impact factor: 3.876

9.  Limited impact of impaired awareness of hypoglycaemia and severe hypoglycaemia on the inflammatory profile of people with type 1 diabetes.

Authors:  Namam Ali; Anna W M Janssen; Martin Jaeger; Lisa Van de Wijer; Wouter van der Heijden; Rob Ter Horst; Priya Vart; Alain van Gool; Leo A B Joosten; Mihai G Netea; Rinke Stienstra; Bastiaan E De Galan; Cees J Tack
Journal:  Diabetes Obes Metab       Date:  2020-09-22       Impact factor: 6.577

10.  Interleukin-18 serum level is elevated in type 2 diabetes and latent autoimmune diabetes.

Authors:  Emanuela Zaharieva; Zdravko Kamenov; Tsvetelina Velikova; Adelina Tsakova; Yosif El-Darawish; Haruki Okamura
Journal:  Endocr Connect       Date:  2017-12-07       Impact factor: 3.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.